Pancreatic Cancer News and Research

RSS

Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.

Real-time live tissue sensitivity assay could be used as a personalized strategy for pancreatic cancer

A new research paper was published in Oncotarget's Volume 14 on September 15, 2023, entitled, "Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma."

19 Sep 2023

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Today, the American Association for Cancer Research (AACR) released the 13th edition of its annual Cancer Progress Report, which chronicles how basic, translational, and clinical cancer research and cancer-related population sciences-;primarily supported by federal investments in the National Institutes of Health (NIH) and the National Cancer Institute (NCI)-;remain vitally important to improving health and saving lives.

13 Sep 2023

Unlocking the secret drivers of deadly pancreatic cancer: New target offers hope for treatment

Researchers identify a super-enhancer-regulated RNA-binding protein cascade that drives the growth of pancreatic ductal adenocarcinoma, a deadly form of pancreatic cancer. The discovery offers a promising new avenue for targeted therapy, potentially sidestepping severe side effects associated with other treatments.

10 Sep 2023

NCCN publishes new guideline focused on preventing and treating cancer-associated blood clots

The National Comprehensive Cancer Network today announced the publication of a new supportive care patient guideline focused on preventing and treating cancer-associated blood clots, also known as venous thromboembolism (VTE).

8 Sep 2023

Enhanced recovery program shows promise in reducing opioid reliance after pancreatic cancer surgery

By improving hospital care pathways, researchers from The University of Texas MD Anderson Cancer Center successfully reduced inpatient opioid use by 50% after pancreatic cancer surgery and cut the median opioid prescription volumes at discharge to zero.

6 Sep 2023

New liquid biopsy technology uses RNA "dark matter" to detect cancer

Cancer is most treatable in its early stages, so finding innovative and non-invasive methods to diagnose cancer early on is crucial for fighting the disease.

31 Aug 2023

New research sheds light on role of KRAS mutations in pancreatic cancer

Researchers at The University of Texas MD Anderson Cancer Center have uncovered a functional role for KRAS mutations in pancreatic cancer and rapidly translated these findings into a novel therapeutic approach combining a KRAS G12D inhibitor with immune checkpoint inhibitors for early- and late-stage KRAS G12D-mutant pancreatic cancer.

24 Aug 2023

Lorazepam linked to shorter progression-free survival in pancreatic cancer patients

Patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer treatment, had a shorter progression-free survival than patients who did not, according to results published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).

17 Aug 2023

Researchers receive DoD grant to target chemotherapy resistance in pancreatic cancer

Researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have been awarded a grant from the U.S. Department of Defense (DoD)'s Congressionally Directed Medical Research Program to target chemotherapy resistance in pancreatic cancer.

17 Aug 2023

High cardiorespiratory fitness may protect against 9 types of cancer in men

Good cardiorespiratory fitness when young is associated with up to a 40% lower risk of developing 9 specific cancers later on-; at least in men-; suggests a large long-term study published online in the British Journal of Sports Medicine.

16 Aug 2023

Study finds way to reverse gene silencing in inner ear cells

A deafened adult cannot recover the ability to hear, because the sensory hearing cells of the inner ear don't regenerate after damage.

14 Aug 2023

Virginia Tech researchers receive $2.6M NIH grant to study new pancreatic cancer treatment

Only about 10 percent of patients survive as long as five years after a diagnosis of pancreatic cancer.

14 Aug 2023

New gene-editing tool helps to study single-base mutations in cancer

A change in just one letter in the code that makes up a cancer-causing gene can significantly affect how aggressive a tumor is or how well a patient with cancer responds to a particular therapy.

10 Aug 2023

What are some recent advancements in proteomics-driven pancreatic oncology research?

The application of proteomics-driven biomarkers for early detection, diagnosis, and treatment of pancreatic cancer.

9 Aug 2023

Computational model can help identify the sites of origin for enigmatic cancers

For a small percentage of cancer patients, doctors are unable to determine where their cancer originated. This makes it much more difficult to choose a treatment for those patients, because many cancer drugs are typically developed for specific cancer types.

7 Aug 2023

Pancreatic Cancer News and Research

Further Reading

Real-time live tissue sensitivity assay could be used as a personalized strategy for pancreatic cancer

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Unlocking the secret drivers of deadly pancreatic cancer: New target offers hope for treatment

NCCN publishes new guideline focused on preventing and treating cancer-associated blood clots

Enhanced recovery program shows promise in reducing opioid reliance after pancreatic cancer surgery

New liquid biopsy technology uses RNA "dark matter" to detect cancer

New research sheds light on role of KRAS mutations in pancreatic cancer

Lorazepam linked to shorter progression-free survival in pancreatic cancer patients

Researchers receive DoD grant to target chemotherapy resistance in pancreatic cancer

High cardiorespiratory fitness may protect against 9 types of cancer in men

Study finds way to reverse gene silencing in inner ear cells

Virginia Tech researchers receive $2.6M NIH grant to study new pancreatic cancer treatment

New gene-editing tool helps to study single-base mutations in cancer

What are some recent advancements in proteomics-driven pancreatic oncology research?

Computational model can help identify the sites of origin for enigmatic cancers

Study discloses vital role of LINC00901 and its regulatory network in pancreatic cancer progression

New study finds no link between common fungus and pancreatic cancer

Nanoengineered bioink improves tumor model accuracy

TTUHSC researcher receives $1.76 million grant to investigate new pancreatic cancer treatment

Newly identified protein plays a key role in the action of emerging anticancer therapies

Breaking Barriers: ANDYSMANCLUB's Fight for Men's Mental Health on World Mental Health Day

Arrayed CRISPR Screening for Revolutionizing Target Discovery

Innovations in baculovirus–insect cell expression systems

Latest News